VANDA PHARMACEUTICALS INC. (VNDA) Total liabilities 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) total liabilities at each fiscal year-end, per SEC filings.
$161.8MFY2025 · since FY2016: $79.0M → $161.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $161.8M | +37.5% |
| FY2024 | $117.7M | +13.6% |
| FY2023 | $103.5M | -3.3% |
| FY2022 | $107.0M | +20.5% |
| FY2021 | $88.9M | +10.8% |
| FY2020 | $80.2M | +10.1% |
| FY2019 | $72.8M | +28.4% |
| FY2018 | $56.7M | -23.4% |
| FY2017 | $74.0M | -6.3% |
| FY2016 | $79.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More VNDA financial trends
VNDA RevenueVNDA Net incomeVNDA Net marginVNDA Gross profitVNDA Gross marginVNDA Operating incomeVNDA Operating marginVNDA Operating cash flowVNDA Free cash flowVNDA Capital expendituresVNDA Return on equityVNDA Stock buybacksVNDA Dividends paidVNDA Total assetsVNDA Shareholders’ equityVNDA overview →